Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Dipanjana Ash

CDA College

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer

Nanomedicine

This is a narrative review of CRISPR-Cas9 delivery concepts for bladder cancer therapy with no original experimental data, clinical trial results, or comparative evidence.

Hypothesis-GeneratingRajesh Kesarla Shayeri Chatterjee Ganguly Swarupananda Mukherjee

Study details

DesignNarrative review article

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support